Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2004
11/24/2004EP1011664B1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
11/24/2004EP0979231B1 Condensed pyridazine derivatives, their production and use
11/24/2004CN1549824A Peptidic compounds selectively binding to p-selectin
11/24/2004CN1549817A Pyrrolo pyrimidines, process for their preparation, their use and pharmaceutical compositions containing them
11/24/2004CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004CN1549814A Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/24/2004CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004CN1549803A 维生素d的类似物 Analogs of vitamin d
11/24/2004CN1549727A Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments
11/24/2004CN1549717A Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them
11/24/2004CN1549715A Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders
11/24/2004CN1549714A Aminoisoxazole derivatives active as kinase inhibitors
11/24/2004CN1548446A Isopamicin and its salt and their prepn
11/24/2004CN1548436A Novel 2-alkyl substituted imidazole compounds
11/24/2004CN1548423A Application of bisbenzylisoquinoline-(7-0-11')-single ether bond alkaloid derivative and analog in treating fibrosis related diseases
11/24/2004CN1548157A SARS resisting medicine action target and its preventing and treating medicine
11/24/2004CN1548136A Pulmonitis treating medicine and its production process
11/24/2004CN1548134A Chinese medicine for treating animal's dyspneic cough and its prepn process
11/24/2004CN1548131A Compound Chinese medicine composition for treating throat inflammation and its prepn process
11/24/2004CN1548129A SARS treating Chinese medicine
11/24/2004CN1548124A Cough-relieving medicine and its prepn
11/24/2004CN1548119A Yiqingwan bolus and its prepn
11/24/2004CN1548117A Honeysuckle-skullcap root-forsythia and its prepn
11/24/2004CN1548113A Bezoar-snake bile-tritillary bolus and its prepn
11/24/2004CN1548104A Compound cordate bouttuynia bolus and its prepn
11/24/2004CN1548101A Honeysuckle-skullcap bolus and its prepn
11/24/2004CN1548098A Cough-eliminating bolus and its prepn
11/24/2004CN1548092A Heat-clearing away cape jasmine-ophiopogon bolus and its prepn
11/24/2004CN1548087A Cough treating bolus and its prepn
11/24/2004CN1548081A Medicine for treating viral pulmonitis
11/24/2004CN1548080A Recipe of medicine for asthma
11/24/2004CN1548064A Recipe and prepn process of lung-benefiting sprayed powder aerosol
11/24/2004CN1548052A Application of aescin and its derivative in preparing medicine for treating acute pulmonary inflammation and hydrops
11/24/2004CN1548044A Fumaric acid-ketotifen dispersion tablet and its prepn process
11/24/2004CN1548041A Andrographis herb prepn and its prepn process and application in preparing medicine
11/24/2004CN1547934A Egg powder for preventing children's respiratory tract diseases and its production process
11/24/2004CN1176939C Fructus gleditsiae total saponin, its preparation method and use in preparation of medicine
11/24/2004CN1176922C 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors
11/24/2004CN1176911C Benzidine-sulfuryl radical substitution pentatomic heterocycle, its preparation method, its medicinal and composition
11/24/2004CN1176688C Medicine for treating acute and chronic pharyngitis and its prepn
11/24/2004CN1176686C Medicine for treating cough and asthma and its prepn
11/24/2004CN1176651C N-(3-benzofuryl) urea derivative
11/24/2004CN1176605C Health-care food with functions of anti-senility, beautifying and moistening skin and prepn. method therefor
11/23/2004US6822087 For anti-asthma/allergy/hypereosinophilia/inflammation/ cancer/tumor drugs; gene expression inhibition
11/23/2004US6821988 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
11/23/2004US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004US6821984 Ring fused pyrazole derivatives as CRF antagonists
11/23/2004US6821973 Compounds
11/23/2004US6821971 For prophyalxis of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease (ibs), septic shock, cardiopulmonary dysfunction, acute respiratory disease, cachexia
11/23/2004US6821966 Antiinflammatory agents
11/23/2004US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004US6821964 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation
11/23/2004US6821950 Antagonist of a g protein-coupled receptor, which has no agonist activity, and which has a cyclic or constrained acyclic structure
11/23/2004CA2332087C Aryl substituted azabenzimidazoles and their use in the treatment of hiv and aids related diseases
11/23/2004CA2329788C Quinoline derivatives
11/23/2004CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents
11/23/2004CA2161346C Sulfonamides and derivatives thereof that modulate the activity of endothelin
11/23/2004CA2135768C Indolocarbazole imides and the use thereof
11/18/2004WO2004099782A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39)
11/18/2004WO2004099207A1 Microcrystal
11/18/2004WO2004099205A1 Azaindole compounds as kinase inhibitors
11/18/2004WO2004099204A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors
11/18/2004WO2004098634A2 Protein arginine n-methyltransferase 2 (prmt-2)
11/18/2004WO2004098605A1 Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap
11/18/2004WO2004082573A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
11/18/2004WO2004071381A3 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
11/18/2004WO2004062686A3 Therapeutic use of modulators of notch
11/18/2004WO2004038406A3 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42)
11/18/2004WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004US20040229927 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
11/18/2004US20040229923 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
11/18/2004US20040229919 As diuretic agent, as an agent for preventing heart or heart tissue damages caused by metabolic or ionic abnormalities associated with ischemia, in the treatment of thrombosis, angina pectoris, asthma, hypertension, nephroedema, pulmonary edema, primary and secondary aldosteronism, Bartter's syndrome
11/18/2004US20040229897 Aid in cytokine biosynthesis
11/18/2004US20040229893 Substituted benzothiazole amide derivatives
11/18/2004US20040229884 Sodium channel blockers
11/18/2004US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004US20040229877 Administering pyrrolotriazine carboxamide and benzamide compounds for therapy of p38 kinase-associated conditions
11/18/2004US20040229870 Certain alkylene diamine-substituted heterocycles
11/18/2004US20040229859 Beta-amino acid compounds as integrin antagonists
11/18/2004US20040229835 Immunostimulatory nucleic acid molecules
11/18/2004US20040228879 Streptococcus pneumoniae polysaccharide is conjugated to protein or peptide, and RSV antigen with adjuvant which is stimmulator of (cytotoxic T) lymphocytes
11/18/2004US20040228857 administration of a human or humanized antibody expressed and glycosylated in a chinese hamster ovaries (CHO) cell expression system to treat T-cell mediated disorders, autoimmune disorders, cancer and infections; vasculitis, arthritis, lupus, psoriasis, multiple sclerosis, graft versus host disease
11/18/2004US20040228806 For use in therapy of chronic obstructive pulmonary disease and asthma; an inhalette capsule contains a mixture of coarser and fine excipient particles
11/18/2004DE102004014929A1 Methoden und Rezepturen zur Hemmung der natürlich vorkommenden Phosphodiesterase Methods and formulations for inhibiting naturally occurring phosphodiesterase
11/18/2004CA2524624A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors
11/18/2004CA2523922A1 Azaindole compounds as kinase inhibitors
11/17/2004EP1477483A1 Vitamin d3 derivatives and remedies using the same
11/17/2004EP1477482A1 Novel phenylalanine derivative
11/17/2004EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004EP1477183A1 Botulinum toxins for modulating cholinergic controlled secretions
11/17/2004EP1476574A2 RNA INTERFERENCE MEDIATED INHIBITION OF TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/17/2004EP1476545A2 Aggrecanase molecules
11/17/2004EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004EP1476466A1 Management of mucosal viscosity by tff monomer peptides
11/17/2004EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b
11/17/2004EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof
11/17/2004EP1476458A2 Rna interference mediated inhibition of platelet derived growth factor (pdgf) and platelet derived growth factor receptor (pdgfr) gene expression using short interfering nucleic acid (sina)
11/17/2004EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport